Last reviewed · How we verify
Chronic idiopathic constipation
Approved treatments
- Linzess · AbbVie
Linzess works by activating the heat-stable enterotoxin receptor to increase fluid secretion in the intestines. - Linzess · TriHealth Inc.
- Pizensy · Braintree Labs
- Amitiza · Sucampo Pharma Llc
Amitiza works by activating chloride channels in the intestines, increasing fluid secretion and promoting bowel movements. - Zelnorm
- Trulance · Salix
Trulance works by stimulating the guanylate cyclase-C receptor to increase fluid secretion in the intestines.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Chronic idiopathic constipation patent landscape — cliff calendar, originator estates, attackable patents
- Chronic idiopathic constipation treatment landscape brief
- Chronic idiopathic constipation treatment updates RSS
Frequently asked questions about Chronic idiopathic constipation
What drugs treat Chronic idiopathic constipation?
Tracked treatments include Linzess, Pizensy, Amitiza, Zelnorm, Trulance.
What is the treatment for Chronic idiopathic constipation?
Standard treatment for Chronic idiopathic constipation includes Linzess, Pizensy, Amitiza, Zelnorm, Trulance. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Chronic idiopathic constipation patent cliff · Chronic idiopathic constipation CI report
- Treatment: Linzess · AbbVie
- Treatment: Linzess · TriHealth Inc.
- Treatment: Pizensy · Braintree Labs
- Treatment: Amitiza · Sucampo Pharma Llc
- Treatment: Zelnorm
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing